Jurkat T-cells were studied for cell proliferation and live ... CD4-PE-Cy7 and activation markers CD25-APC (IL-2 receptor) and CD134-PE (TNF receptor). Activated lymphocytes were then analysed for ...
1). RubrYc’s lead programs include RTX-002, an anti-PD-1 agonist for serious autoimmune diseases such as systemic lupus erythematosus and multiple sclerosis, and RTX-003, an anti-CD25 antibody ...